Suppr超能文献

一例对S-1有反应的口腔鳞状细胞癌病例

[A case of oral squamous cell carcinoma responding to S-1].

作者信息

Harada Koji, Tamatani Tetsuya, Bando Takashi, Yoshida Hideo

机构信息

Department of Therapeutic Regulation for Oral Tumors, Graduate School of Health and Bioscience, Tokushima University.

出版信息

Gan To Kagaku Ryoho. 2007 Sep;34(9):1455-8.

Abstract

A 76-year-old patient with oral squamous cell carcinoma was treated by chemotherapy with S-1. S-1 (100 mg/body/day) was orally administered for 4 weeks followed by a 2-week rest period as one course. The primary lesion markedly decreased at 7 days after the beginning of S-1 treatment, and disappeared after one course of S-1. After two courses, the primary lesion was assessed to show a complete response (CR),and no tumor cells were identified as a result of biopsy. In addition, the value of tumor marker SCC decreased from 2.13 ng/mL before treatment to 0.68 ng/mL after two courses of S-1. Although the patient is still taking UFT, she is well with no signs of recurrence 50 months from the initial treatment.

摘要

一名76岁的口腔鳞状细胞癌患者接受了S-1化疗。S-1(100毫克/体/天)口服给药4周,随后休息2周作为一个疗程。S-1治疗开始7天后,原发灶明显缩小,一个疗程后消失。两个疗程后,评估原发灶显示完全缓解(CR),活检未发现肿瘤细胞。此外,肿瘤标志物SCC的值从治疗前的2.13纳克/毫升降至S-1两个疗程后的0.68纳克/毫升。尽管该患者仍在服用优福定,但自初始治疗50个月以来,她情况良好,没有复发迹象。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验